Redeye: Tessin - All eyes on the new financing agreement
Redeye updates its estimates after reviewing Tessin's Q2 report, which was in line with our expectations. We anticipate a trend shift in H2, particularly in Q4, as capital from the new financing agreements is expected to be allocated to new loans.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/